Nootropic effect of nicotine on carbon monoxide (CO)-induced delayed amnesia in mice

Psychopharmacology (Berl). 1994 Sep;116(1):33-9. doi: 10.1007/BF02244868.

Abstract

The effects of nicotine on carbon monoxide (CO)-induced amnesia in mice were investigated using a step-down type passive avoidance task. Mice were exposed to CO 3 times at 1-h intervals, 7 days before the first training and retention test and 24 h after the first training session. Memory deficiency occurred in mice when training commenced more than 3 days after CO exposure (delayed amnesia): the median step-down latency in the retention test of the CO-exposed group was significantly shorter than that of the control group. Administration of (-)-nicotine (15.6 and 31.3 nmol/kg, IP) 15 min before the first training session prolonged the step-down latency in the CO-exposed group, but (+)-nicotine did not. To determine whether this effect of (-)-nicotine was mediated via nicotinic cholinergic receptors, we attempted to block its action using a nicotinic acetylcholine receptor antagonist (mecamylamine). Mecamylamine (1.25 mumol/kg) blocked the effect of (-)-nicotine (31.3 nmol/kg) on delayed amnesia. Administration of (-)-nicotine (15.6-62.5 nmol/kg) immediately after the first training session failed to ameliorate learning ability in the CO-exposed group. These results suggest that (-)-nicotine potentiates the nicotinic cholinergic neuronal system and may potentiate acquisition of memory.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amnesia / chemically induced
  • Amnesia / drug therapy*
  • Amnesia / psychology
  • Animals
  • Avoidance Learning / drug effects
  • Carbon Monoxide Poisoning / psychology*
  • Electroshock
  • Male
  • Mecamylamine / pharmacology
  • Memory / drug effects
  • Mice
  • Mice, Inbred Strains
  • Motor Activity / drug effects
  • Nicotine / antagonists & inhibitors
  • Nicotine / therapeutic use*
  • Nicotinic Antagonists
  • Nootropic Agents / antagonists & inhibitors
  • Nootropic Agents / therapeutic use*
  • Receptors, Nicotinic / drug effects

Substances

  • Nicotinic Antagonists
  • Nootropic Agents
  • Receptors, Nicotinic
  • Mecamylamine
  • Nicotine